特应性皮炎临床试验招募信息（全球在招）

这里汇总了全球正在招募患者的 特应性皮炎（国际通用名 atopic dermatitis）新药临床试验，包含试验分期、招募状态、开展国家和研究团队联系方式，全部以中文呈现。数据实时来自全球最大的临床试验注册库 ClinicalTrials.gov。本页同时覆盖湿疹、异位性皮炎等说法。

正在招募的特应性皮炎新药试验

• Study of CM512 in Patients With Moderate-to-Severe Atopic Dermatitis

  II 期招募中中国NCT06947980

• A Multicenter, Randomized, Double-blind, Vehicle Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 Gel in Adult Subjects With Mild to Moderate Atopic Dermatitis

  II 期招募中中国NCT07598383

• Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases

  不适用招募中法国NCT06599411

• Virtual Reality for Pain Management During Dupilumab Injection

  不适用招募中加拿大NCT06182436

• A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

  II 期招募中美国澳大利亚加拿大New ZealandNCT07037901

• A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema

  III 期招募中美国中国德国HungaryNCT06807281

• Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  不适用招募中美国NCT00177268

• A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis

  III 期招募中美国Belgium加拿大CroatiaNCT06311682

• The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease

  IV 期招募中美国NCT07487831

• A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring

  不适用招募中美国NCT05721937

• Efficacy and Safety of Methotrexate Versus Placebo in Adults With Atopic Dermatitis.

  III 期招募中Czechia法国意大利PolandNCT06239311

• The Impact of Botox on Neuroimmune Interactions in Atopic Dermatitis

  I 期招募中美国NCT06928246